Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Michael J. Fox Foundation

Michael J. Fox Foundation

May 14, 2020

Erisyon Wins $189K Michael J. Fox Foundation Grant for Protein Biomarker Discovery

Erisyon will use its single-molecule protein sequencing technology to detect and validate biomarkers for early detection of Parkinson's disease.

Oct 24, 2019

New Parkinson's Disease RNA-Seq Dataset Enables Search for Disease Biomarkers

Premium

The Michael J. Fox Foundation-led project aims to lead researchers to new insights about biomarkers indicating Parkinson's disease progression.

Jan 30, 2018

NIH Launches Parkinson's Disease Research Partnership

The partnership includes biopharmaceutical, life science, and non-profit organizations, as well as several US government agencies.

Oct 30, 2017

Michael J. Fox Foundation Grants $4M to 23andMe for New Parkinson's Disease Collaboration

The study will provide researchers, drugmakers, regulators, and payors with insight into the genetics of the disease and experience of the patients.

Oct 04, 2017

GNS Healthcare's Machine Learning Platform Leads to Novel Parkinson's Gene Discovery

Premium

Using data from the Parkinson's Progression Markers Initiative, GNS Healthcare identifies genetic and molecular markers of rapid motor progression.

Apr 12, 2016

STSI Launches Study to Improve Screening Accuracy for Parkinson's Disease

Premium

The study will screen patients using a combination of genotyping and wireless sensors to develop a better diagnostic method. 

Oct 03, 2014

Michael J. Fox Foundation Funds GVSU Research into Parkinson's Biomarker

NEW YORK (GenomeWeb) – The Michael J. Fox Foundation for Parkinson's Research has awarded Sok Kean Khoo, an associate professor of molecular genomics at Grand Valley State University, a $110,000 grant to study molecular biomarkers for monitoring the advancement of Parkinson's disease.

Jun 27, 2012

KineMed Receives $1.2M from Michael J. Fox Foundation for Parkinson's Biomarkers

NEW YORK (GenomeWeb News) – KineMed today reported the Michael J. Fox Foundation has awarded it an additional $1.2 million to continue development of kinetic biomarkers for Parkinson's disease.

Jan 25, 2012

Lucigen Receives $187K Grant from Michael J. Fox Foundation

NEW YORK (GenomeWeb News) – Lucigen today announced it has received a $187,000 grant from the Michael J. Fox Foundation to study a protein that has been implicated in Parkinson's disease.

Jun 24, 2011

23andMe-Led Team Reports on Findings from Web-Based Parkinson's GWAS

A 23andMe and Parkinson's Institute team has tracked down two new risk loci for Parkinson's disease and verified many more through a web-based genome-wide association study involving more than 3,400 cases and nearly 30,000 controls.

Pages

The Scan

Should Also Work

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.

Worries About Increased Deadliness

A new analysis suggests the B.1.1.7 strain of SARS-CoV-2 could be deadlier than previous ones, according to the Guardian.

Merck Stops SARS-CoV-2 Vaccine Development

NPR reports Merck is halting the development of its two candidate SARS-CoV-2 vaccines following disappointing Phase 1 results.

PLOS Papers on Rare Venous Thromboembolism Variant, Vector Mosquito LncRNAs, More

In PLOS this week: gene mutation linked to inherited venous thrombosis, lncRNA patterns in the Asian tiger mosquito, and more.

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.